Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1085 studies found for:    "Hodgkin Disease"
Show Display Options
Download search resultsDownload the search results for:
"Hodgkin Disease" (1085 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Mantle Irradiation for Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Procedure: Mantle irradiation
2 Completed A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: MDX-060
3 Terminated Breast-Sparing Proton Therapy for Hodgkin's Disease
Condition: Hodgkins Disease
Intervention: Radiation: Proton
4 Completed
Has Results
AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Drug: G-CSF Plus Plerixafor
5 Unknown  Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: R-mabHD;   Drug: ABVD
6 Completed Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)
Condition: Hodgkin's Disease
Interventions: Drug: Methotrexate;   Drug: Leucovorin calcium;   Drug: 6-Thioguanine
7 Completed Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Condition: Hodgkin's Disease
Interventions: Drug: Gemcitabine;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Antithymocyte Globulin;   Procedure: Allogeneic Stem Cell Infusion;   Drug: Tacrolimus;   Drug: Filgrastim (G-CSF);   Drug: Methotrexate
8 Completed Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy
Condition: Hodgkin Disease
Interventions: Drug: Filgrastim SD/01;   Drug: Adriamycin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: DTIC
9 Active, not recruiting Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Condition: Hodgkin's Disease
Intervention: Procedure: Echo/Stress Echo
10 Terminated Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease
Condition: Hodgkin Disease
Interventions: Drug: Doxorubicin;   Drug: Vinblastine;   Drug: Cyclophosphamide;   Drug: Etoposide;   Drug: Vincristine;   Drug: Bleomycin;   Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Prednisone
11 Completed Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
Condition: Hodgkin's Disease
Interventions: Procedure: Pulmonary Function Tests;   Procedure: CAT Scan
12 Completed Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)
Condition: Advanced Hodgkin Disease
Intervention: Drug: COPPEBVCAD vs BEACOPP vs ABVD
13 Unknown  Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET
Condition: Hodgkin Disease
Interventions: Drug: Combined chemotherapy (ABVD, BACOPP-D);   Procedure: Radiation therapy
14 Completed A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Ifosfamide, Gemcitabine, Vinorelbine;   Drug: Bortezomib + IGEV
15 Not yet recruiting A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Brentuximab vedotin;   Drug: Doxorubicin;   Drug: Vinblastine;   Drug: Dacarbazine
16 Completed A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Conditions: Pediatric;   Hodgkin's Disease
Interventions: Drug: COPP/ABV;   Drug: intensive chemo with concurrent growth factor
17 Recruiting Brazilian Prospective Hodgkin Lymphoma Registry
Conditions: Hodgkin Lymphoma;   Hodgkin Disease
Intervention:
18 Terminated Personalised Program for Women Treated for Hodgkin Disease
Conditions: Hodgkin Disease;   Breast Cancer
Intervention: Procedure: intensive screening
19 Active, not recruiting
Has Results
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
Conditions: Lymphoma;   Hodgkin's Disease
Interventions: Drug: Melphalan;   Drug: Ara-C;   Drug: VP-16;   Drug: BCNU;   Drug: Rituxan;   Drug: Stem Cells
20 Recruiting Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
Condition: Hodgkin's Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.